Novel peptide antagonists for modulating GPCR pharmacology

Novel cardioprotective vasodilator peptides with enhanced affinity for AM and CGRP receptors have been developed.

This technology informs development of AM2/IMD-based pharmacological therapeutics with potential applications in diabetes, obesity, cardiovascular, cardiopulmonary, and renal diseases.
 
IP status:

• 15/568,129 (US)
• 62/721,713 (US)